Arlington Trust Co LLC Lowers Stock Position in The Procter & Gamble Company (NYSE:PG)

Arlington Trust Co LLC trimmed its holdings in The Procter & Gamble Company (NYSE:PG) by 8.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,536 shares of the company’s stock after selling 230 shares during the quarter. Arlington Trust Co LLC’s holdings in Procter & Gamble were worth $439,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of PG. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at $29,000. Ruedi Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC purchased a new position in shares of Procter & Gamble in the second quarter worth $34,000. Finally, Quest Partners LLC bought a new position in shares of Procter & Gamble during the second quarter valued at $36,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Down 0.0 %

Shares of NYSE:PG traded down $0.08 on Friday, reaching $165.10. The company had a trading volume of 5,455,095 shares, compared to its average volume of 6,645,703. The firm has a market capitalization of $388.82 billion, a PE ratio of 28.47, a PEG ratio of 3.59 and a beta of 0.41. The firm’s 50 day simple moving average is $171.62 and its 200-day simple moving average is $167.91. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.83 earnings per share. As a group, analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.44%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Analysts Set New Price Targets

PG has been the subject of a number of recent analyst reports. Citigroup boosted their target price on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft increased their price target on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Stifel Nicolaus upped their price objective on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research report on Monday, July 22nd. Finally, Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and cut their price target for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $177.00.

Insider Buying and Selling

In related news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the sale, the chief executive officer now owns 263,537 shares in the company, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 389,144 shares of company stock valued at $66,184,385 over the last ninety days. Company insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.